168 related articles for article (PubMed ID: 31912772)
1. Anti-Inflammatory and Gastroprotective Properties of Aspirin - Entrapped Solid Lipid Microparticles.
Chime SA; Akpa PA; Ugwuanyi CC; Attama AA
Recent Pat Inflamm Allergy Drug Discov; 2020; 14(1):78-88. PubMed ID: 31912772
[TBL] [Abstract][Full Text] [Related]
2. Formulation in vitro and in vivo evaluation of SRMS-based heterolipid-templated homolipid delivery system for diclofenac sodium.
Mumuni M; Attama AA; Kunle OO
Drug Deliv; 2016; 23(3):917-25. PubMed ID: 24959939
[TBL] [Abstract][Full Text] [Related]
3. Pharmacodynamics of piroxicam from novel solid lipid microparticles formulated with homolipids from Bos indicus.
Nnamani PO; Attama AA; Kenechukwu FC; Ibezim EC; Adikwu MU
Curr Drug Deliv; 2013 Dec; 10(6):645-55. PubMed ID: 23140234
[TBL] [Abstract][Full Text] [Related]
4. Testosterone solid lipid microparticles for transdermal drug delivery. Formulation and physicochemical characterization.
El-Kamel AH; Al-Fagih IM; Alsarra IA
J Microencapsul; 2007 Aug; 24(5):457-75. PubMed ID: 17578735
[TBL] [Abstract][Full Text] [Related]
5. Novel formulation of solid lipid microparticles of curcumin for anti-angiogenic and anti-inflammatory activity for optimization of therapy of inflammatory bowel disease.
Yadav VR; Suresh S; Devi K; Yadav S
J Pharm Pharmacol; 2009 Mar; 61(3):311-21. PubMed ID: 19222903
[TBL] [Abstract][Full Text] [Related]
6. Sustained-release diclofenac potassium-loaded solid lipid microparticle based on solidified reverse micellar solution: in vitro and in vivo evaluation.
Chime SA; Attama AA; Builders PF; Onunkwo GC
J Microencapsul; 2013; 30(4):335-45. PubMed ID: 23057661
[TBL] [Abstract][Full Text] [Related]
7. Pharmacodynamics of diclofenac from novel Eudragit entrapped microspheres.
Momoh MA; Kenechukwu FC; Adedokun MO; Odo CE; Attama AA
Drug Deliv; 2014 May; 21(3):193-203. PubMed ID: 24171400
[TBL] [Abstract][Full Text] [Related]
8. Formulation and Evaluation of Novel Solid Lipid Microparticles for the Sustained Release of Ofloxacin.
Hooda A; Sradhanjali M; Popsy
Pharm Nanotechnol; 2017; 5(4):329-341. PubMed ID: 29278216
[TBL] [Abstract][Full Text] [Related]
9. Enhanced anti-inflammatory and ulcerogenicity of Ibuprofen microsphere formulations using Irvingia wombolu fat (IRW) and moringa oil (MO) as co-lipids.
Gugu TH; Agu GC; Uronnachi EM; Chime SA
BMC Complement Med Ther; 2023 Jul; 23(1):249. PubMed ID: 37468938
[TBL] [Abstract][Full Text] [Related]
10. Formulation development and evaluation of the anti-malaria properties of sustained release artesunate-loaded solid lipid microparticles based on phytolipids.
Chinaeke EE; Chime SA; Onyishi VI; Attama AA; Okore VC
Drug Deliv; 2015; 22(5):652-65. PubMed ID: 24479677
[TBL] [Abstract][Full Text] [Related]
11. Ethyl cellulose nanoparticles as a platform to decrease ulcerogenic potential of piroxicam: formulation and in vitro/in vivo evaluation.
El-Habashy SE; Allam AN; El-Kamel AH
Int J Nanomedicine; 2016; 11():2369-80. PubMed ID: 27307735
[TBL] [Abstract][Full Text] [Related]
12. Gastroprotective and ulcer healing effects of nitric oxide-releasing non-steroidal anti-inflammatory drugs.
Brzozowski T; Konturek PC; Konturek SJ; Sliwowski Z; Drozdowicz D; Kwiecień S; Pajdo R; Ptak A; Pawlik M; Hahn E
Dig Liver Dis; 2000 Oct; 32(7):583-94. PubMed ID: 11142556
[TBL] [Abstract][Full Text] [Related]
13. A new lipid-based oral delivery system of erythromycin for prolong sustain release activity.
Momoh MA; Ossai EC; Chidozie OE; Precscila OO; Kenechukwu FC; Ofokansi KO; Attama AA; Olobayo KO
Mater Sci Eng C Mater Biol Appl; 2019 Apr; 97():245-253. PubMed ID: 30678909
[TBL] [Abstract][Full Text] [Related]
14. Formulation design, in vitro characterizations and anti-malarial investigations of artemether and lumefantrine-entrapped solid lipid microparticles.
Agbo C; Umeyor C; Kenechukwu F; Ogbonna J; Chime S; Lovelyn C; Agubata O; Ofokansi K; Attama A
Drug Dev Ind Pharm; 2016 Oct; 42(10):1708-21. PubMed ID: 27095388
[TBL] [Abstract][Full Text] [Related]
15. Modulating drug release profiles by lipid semi solid matrix formulations for BCS class II drug--an in vitro and an in vivo study.
M K; Sistla R; Shastri NR
Drug Deliv; 2015 May; 22(3):418-26. PubMed ID: 24471823
[TBL] [Abstract][Full Text] [Related]
16. Preparation, Characterization and Anti-Ulcer Efficacy of Sanguinarine Loaded Solid Lipid Nanoparticles.
Sun Q; Li W; Li H; Wang X; Wang Y; Niu X
Pharmacology; 2017; 100(1-2):14-24. PubMed ID: 28334726
[TBL] [Abstract][Full Text] [Related]
17. Solid lipid nanoparticles (SLNs) gels for topical delivery of aceclofenac in vitro and in vivo evaluation.
Dasgupta S; Ghosh SK; Ray S; Mazumder B
Curr Drug Deliv; 2013 Dec; 10(6):656-66. PubMed ID: 24274634
[TBL] [Abstract][Full Text] [Related]
18. In vitro and in vivo evaluation of single-unit commercial immediate-and sustained-release capsules compared with multiple-unit polystyrene microparticles dosage forms of indomethacin.
Tamilvanan S; Sa B
PDA J Pharm Sci Technol; 2008; 62(3):177-90. PubMed ID: 18661867
[TBL] [Abstract][Full Text] [Related]
19. Formulation of novel sustained release rifampicin-loaded solid lipid microparticles based on structured lipid matrices from Moringa oleifera.
Onyishi IV; Chime SA; Ogudiegwu EO
Pharm Dev Technol; 2015; 20(5):546-54. PubMed ID: 24964095
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the Properties of Encapsulated Stavudine Microparticulate Lipid-based Drug Delivery System in Immunocompromised Wistar Rats.
Chime SA; Onunkwo GC; Attama AA
Curr HIV Res; 2020; 18(4):237-247. PubMed ID: 32386495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
